Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the PK Lead-in Phase of this study is: - To evaluate the steady state pharmacokinetics (PK) and confirm the dose of LDV/SOF FDC in chronic HCV-infected pediatric subjects The primary objective of the Treatment Phase of this study is: - To evaluate the safety and tolerability of LDV/SOF FDC +/- RBV for 12 or 24 weeks in chronic HCV-infected pediatric subjects
Inclusion criteria
- Chronic hepatitis C virus infection